Back to search
FDAFDA · Food and drugs·Recall number D-0172-2023

FentaNYL Citrate 2.5mg/50mL (50mcg/mL) Injection Solution, Preservative-Free IV Injection 50mL Cassette, Rx Only, OurPharma, LLC, 2512 S. City Lake Rd., Fayetteville, AR 72701, NDC 73013-1001-01.

Published February 1, 2023 · Recall initiated: January 13, 2023

Summary

FDA records drug Class III recall D-0172-2023, published February 1, 2023 and initiated January 13, 2023. Recalling firm: OurPharma LLC; Status: Terminated; Reported quantity: 768 cassettes; Lot: Lots: 100122080003, Exp. 2/26/2023; 100122090001, Exp. 3/07/2023; 100122100002, Exp. 4/05/2023. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Short Fill: Underfilled units.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
OurPharma LLC
Distributor
IL and MO
Lot
Lots: 100122080003, Exp. 2/26/2023; 100122090001, Exp. 3/07/2023; 100122100002, Exp. 4/05/2023
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was FentaNYL Citrate 2.5mg/50mL (50mcg/mL) Injection Solution, Preservative-Free IV Injection 50mL Cassette, Rx Only, OurPharma, LLC, 2512 S. City Lake Rd., Fayetteville, AR 72701, NDC 73013-1001-01. recalled?

Yes. FDA published recall D-0172-2023 on February 1, 2023. Reported hazard: Short Fill: Underfilled units.

What should I do if I have this product?

Voluntary: Firm initiated · Letter